Artemis Therapeutics Inc.
ATMSOTCFinancial Services
$0.50
$-1.39(-73.65%)
Market Cap$55792932
P/E Ratio—
52W High$4.5
52W Low$0.1121
Artemis Therapeutics Inc. (ATMS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ATMS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2023Report Date: May 18, 2023EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q2 FY2023
FY ends December
Report Date
May 18, 2023
After Market Close
ATMS reports quarterly as a OTC-listed Shell Companies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2024 | May 16, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 29, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 13, 2023 | — | — | — | — | — | — |
| ◌ Q3 FY2023 | Aug 21, 2023 | — | — | — | — | — | — |
| — Q2 FY2023 | May 18, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2023 | Mar 31, 2023 | — | -$0.09 | — | $0.00B | — | — |
| — Q4 FY2022 | Nov 14, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q3 FY2022 | Aug 22, 2022 | — | -$0.01 | — | $0.00B | — | — |
Q2 FY2024
May 16, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 29, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 13, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 21, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 18, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Mar 31, 2023
EPS Actual
-$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Nov 14, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Aug 22, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for ATMS.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2023 | May 18, 2023 | — | $0.30 | $0.51 | +71.14% |
| — Q1 FY2023 | Mar 31, 2023 | — | $0.60 | $0.60 | +0.00% |
| — Q4 FY2022 | Nov 14, 2022 | — | $1.40 | $1.50 | +7.14% |
| — Q3 FY2022 | Aug 22, 2022 | — | $1.50 | $1.50 | +0.00% |
| — Q2 FY2022 | May 23, 2022 | — | $2.99 | $2.93 | -2.01% |
| — Q1 FY2022 | Mar 3, 2022 | — | $1.01 | $1.00 | -0.99% |
| — Q4 FY2021 | Nov 10, 2021 | — | $1.01 | $0.76 | -24.65% |
| — Q2 FY2021 | Jun 30, 2021 | — | $6.00 | $6.99 | +16.50% |
Q2 FY2023+71.14%
Report Date
May 18, 2023
EPS Beat/Miss
—
Price Before
$0.30
Price After
$0.51
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$0.60
Price After
$0.60
Q4 FY2022+7.14%
Report Date
Nov 14, 2022
EPS Beat/Miss
—
Price Before
$1.40
Price After
$1.50
Q3 FY2022+0.00%
Report Date
Aug 22, 2022
EPS Beat/Miss
—
Price Before
$1.50
Price After
$1.50
Q2 FY2022-2.01%
Report Date
May 23, 2022
EPS Beat/Miss
—
Price Before
$2.99
Price After
$2.93
Q1 FY2022-0.99%
Report Date
Mar 3, 2022
EPS Beat/Miss
—
Price Before
$1.01
Price After
$1.00
Q4 FY2021-24.65%
Report Date
Nov 10, 2021
EPS Beat/Miss
—
Price Before
$1.01
Price After
$0.76
Q2 FY2021+16.50%
Report Date
Jun 30, 2021
EPS Beat/Miss
—
Price Before
$6.00
Price After
$6.99
Beat Rate0 / 8 quarters
Largest Move+71.14% (Q2 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ATMS ends December
Artemis Therapeutics Inc. (ATMS) most recently reported earnings on May 18, 2023 for Q2 FY2023, posting EPS of $-0.00 (in line with the analyst consensus of —). The next ATMS earnings date is expected around September 1, 2026.
Each quarter, investors track ATMS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ATMS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ATMS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ATMS earnings · 4 questionsArtemis Therapeutics Inc.'s next earnings report is expected around September 1, 2026. ATMS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ATMS historically reports after market close (AMC).
ATMS earnings datewhen is ATMS earningsATMS next earnings datewhen does ATMS report earningsATMS earnings calendar
▸ Source: FMP · Artemis Therapeutics Inc. SEC filings · US GAAP · Artemis Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026